Company intelligence / Profile preview

Pegasus Laboratories

Pensacola, Florida, United Statespegasuslabs.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Pegasus Laboratories is a full-service CDMO specializing in the development, manufacturing, and commercialization of veterinary pharmaceuticals and supplements. Their products address behavior, urinary incontinence, seizure management, among other animal wellness indications. They operate a DEA-approved cGMP facility with over 100 employees. The company is 100% employee-owned under PBI-Gordon Companies since its acquisition in 1999[1][2][6].

Therapeutic areas: NeurologyPsychiatryNephrology
Modalities: Small moleculeBiologic
Industry: Veterinary

Beyond the preview

Go deeper on Pegasus Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pegasus Laboratories.

Explore the full profile